title: Toxicity and pharmacokinetics of intravitreally injected ciprofloxacin in rabbit eyes.
abstract: To assess the toxicity of intraocular injection of ciprofloxacin, 22 New Zealand white rabbits received midvitreal injections of 100, 200, 400, 800 or 3200 micrograms of ciprofloxacin in 0.1 mL of distilled water (39 eyes) or 0.1 mL of distilled water only (5 eyes). The ocular pharmacokinetics of intravitreally injected ciprofloxacin was determined by aqueous humour and vitreous sampling 1, 2, 4, 8, 12, 18 or 24 hours after midvitreal injection of 100 micrograms of the drug in one eye each of 25 New Zealand white rabbits. The samples were analysed by means of a disc diffusion bioassay. No ocular damage was noted on ophthalmoscopy at any of the concentrations tested. Histologic study showed mild, transient vacuolation of the nerve-fibre layer in all eyes, including the control eyes, 2 hours after injection; at 24 hours no vacuolation was evident except at concentrations of 800 and 3200 micrograms, at which plexiform layer damage was evident. Peak aqueous and vitreous levels of ciprofloxacin were obtained at 1 hour (0.59 and 27.26 micrograms/mL respectively); the vitreous level fell to below 1.0 micrograms/mL 12 hours after injection. We conclude that intravitreally injected ciprofloxacin may be a safe and useful antibiotic in the treatment of aminoglycoside-resistant bacterial endophthalmitis.
authors.affiliation: Department of Ophthalmology, University of Toronto.
authors.forename: D S
authors.initials: DS
authors.lastname: Rootman
authors.forename: P
authors.initials: P
authors.lastname: Savage
authors.forename: S M
authors.initials: SM
authors.lastname: Hasany
authors.forename: L
authors.initials: L
authors.lastname: Chisholm
authors.forename: P K
authors.initials: PK
authors.lastname: Basu
mesh_terms: D000818:Animals; D001082:Aqueous Humor / Q000378:metabolism; D002939:Ciprofloxacin / Q000493:pharmacokinetics* / Q000633:toxicity*; D009877:Endophthalmitis / Q000188:drug therapy / Q000382:microbiology; D015818:Eye Infections, Bacterial / Q000188:drug therapy; D007267:Injections; D009887:Ophthalmoscopy; D010786:Photoreceptor Cells / Q000187:drug effects / Q000648:ultrastructure; D011817:Rabbits; D012160:Retina / Q000187:drug effects* / Q000378:metabolism* / Q000648:ultrastructure; D014822:Vitreous Body / Q000378:metabolism
chemical_list: D002939:Ciprofloxacin